BioScrip Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
BioScrip (BIOS) PT Raised to $4 at Jefferies; Reiterates Buy
August 9, 2017 8:35 AM EDTJefferies raised its price target on BioScrip (NASDAQ: BIOS) to $4.00 (from $3.00) while maintaining a Buy rating following 2Q. EBITDA of $10MM was ahead of consensus and nearly doubled on a sequential basis, while Core revenue was up 2% Q/Q and grew to 73.1% of total... More
BioScrip (BIOS) Misses Q2 EPS by 14c, Revs Modestly Lower; Reiterates Outlook
August 8, 2017 8:03 AM EDTBioScrip (NASDAQ: BIOS) reported Q2 EPS of ($0.26), $0.14 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $218.1 million versus the consensus estimate of $220.17 million.
2017 Guidance
The Company is reiterating its prior guidance of adjusted EBITDA in the range of... More
